![Richard Duke](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Richard Duke
Directeur Général chez MenoGenix, Inc.
Postes actifs de Richard Duke
Sociétés | Poste | Début | Fin |
---|---|---|---|
The University of Colorado | Corporate Officer/Principal | - | - |
ApopLogic Pharmaceuticals, Inc.
![]() ApopLogic Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology ApopLogic Pharmaceuticals, Inc. researches and develops pharmaceutical products. It focuses on the development and commercialization of B201, is a rationally-designed synthetic peptide dimer of a potent decapeptide bradykinin B1&B2 receptor antagonist that directly induces apoptosis of cancer cells that overexpress these receptors and AP-300 is used in the neo-adjuvant or adjuvant setting with standard-of-care agents to improve survival outcomes in humans and companion animals with any accessible solid tumor including carcinomas, sarcomas and lymphomas. The company was founded in 2006 by Richard C. Duke, Donald Bellgrau, Paul A. Bunn, Daniel Chan, Lajos Gera, Jaime F. Modiano and John M. Stewart and is headquartered in Aurora, CO. | Directeur Général | 01/01/2006 | - |
Fondateur | 01/01/2006 | - | |
President | 01/01/2006 | - | |
MenoGenix, Inc.
![]() MenoGenix, Inc. BiotechnologyHealth Technology MenoGenix, Inc. operates as a biotechnology company. It focuses on development of drugs for menopause and the menopause diseases. The company was founded by Debra M. Duke and Jonathan Kaufman in 2010 and is headquartered in Aurora, CO. | Directeur Général | - | - |
Président | - | - |
Historique de carrière de Richard Duke
Anciens postes connus de Richard Duke
Sociétés | Poste | Début | Fin |
---|---|---|---|
Colorado Institute For Drug Device & Diagnostic Development
![]() Colorado Institute For Drug Device & Diagnostic Development Medical/Nursing ServicesHealth Services The Colorado Institute For Drug Device & Diagnostic Development provides health maintenance services. The American company was founded by Richard C. Duke. | Directeur Technique/Scientifique/R&D | - | - |
Fondateur | - | - | |
Sierra Neuropharmaceuticals, Inc.
![]() Sierra Neuropharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Sierra Neuropharmaceuticals, Inc. is a biopharmaceutical company focused on the development and commercialization of centrally-administered, small molecule therapeutics for the treatment of severe central nervous systems diseases refractory to oral medications. These include epilepsy, schizophrenia, bipolar disorder, anxiety disorders and major depression. The company uses a proprietary drug development process to reformulate pharmaceuticals for direct delivery to the brain via standard implantable pumps. The company was founded in 2005 and is headquartered in Aurora, CO. | Directeur/Membre du Conseil | - | - |
Peptivir, Inc.
![]() Peptivir, Inc. Pharmaceuticals: MajorHealth Technology PeptiVir, Inc. operates as a biopharmaceutical company focused on the development and commercialization of a conformationally-constrained, synthetic peptide-based vaccine platform for the prevention of viral diseases. The company is headquartered in Aurora, CO. | Directeur Général | - | - |
Président | - | - | |
GLOBEIMMUNE, INC. | Directeur/Membre du Conseil | 10/08/1995 | - |
Directeur Général | 10/08/1995 | - | |
Fondateur | 10/02/1995 | - | |
President | 10/08/1995 | - |
Formation de Richard Duke
The University of Colorado | Doctorate Degree |
McGill University | Undergraduate Degree |
Statistiques
Internationale
Etats-Unis | 8 |
Canada | 2 |
Opérationnelle
Chief Executive Officer | 4 |
Founder | 3 |
President | 2 |
Sectorielle
Health Technology | 6 |
Consumer Services | 3 |
Health Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 1 |
---|---|
GLOBEIMMUNE, INC. | Health Technology |
Entreprise privées | 5 |
---|---|
ApopLogic Pharmaceuticals, Inc.
![]() ApopLogic Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology ApopLogic Pharmaceuticals, Inc. researches and develops pharmaceutical products. It focuses on the development and commercialization of B201, is a rationally-designed synthetic peptide dimer of a potent decapeptide bradykinin B1&B2 receptor antagonist that directly induces apoptosis of cancer cells that overexpress these receptors and AP-300 is used in the neo-adjuvant or adjuvant setting with standard-of-care agents to improve survival outcomes in humans and companion animals with any accessible solid tumor including carcinomas, sarcomas and lymphomas. The company was founded in 2006 by Richard C. Duke, Donald Bellgrau, Paul A. Bunn, Daniel Chan, Lajos Gera, Jaime F. Modiano and John M. Stewart and is headquartered in Aurora, CO. | Health Technology |
Sierra Neuropharmaceuticals, Inc.
![]() Sierra Neuropharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Sierra Neuropharmaceuticals, Inc. is a biopharmaceutical company focused on the development and commercialization of centrally-administered, small molecule therapeutics for the treatment of severe central nervous systems diseases refractory to oral medications. These include epilepsy, schizophrenia, bipolar disorder, anxiety disorders and major depression. The company uses a proprietary drug development process to reformulate pharmaceuticals for direct delivery to the brain via standard implantable pumps. The company was founded in 2005 and is headquartered in Aurora, CO. | Health Technology |
Peptivir, Inc.
![]() Peptivir, Inc. Pharmaceuticals: MajorHealth Technology PeptiVir, Inc. operates as a biopharmaceutical company focused on the development and commercialization of a conformationally-constrained, synthetic peptide-based vaccine platform for the prevention of viral diseases. The company is headquartered in Aurora, CO. | Health Technology |
MenoGenix, Inc.
![]() MenoGenix, Inc. BiotechnologyHealth Technology MenoGenix, Inc. operates as a biotechnology company. It focuses on development of drugs for menopause and the menopause diseases. The company was founded by Debra M. Duke and Jonathan Kaufman in 2010 and is headquartered in Aurora, CO. | Health Technology |
Colorado Institute For Drug Device & Diagnostic Development
![]() Colorado Institute For Drug Device & Diagnostic Development Medical/Nursing ServicesHealth Services The Colorado Institute For Drug Device & Diagnostic Development provides health maintenance services. The American company was founded by Richard C. Duke. | Health Services |
- Bourse
- Insiders
- Richard Duke
- Expérience